Product Information
FIORICET 50-300-40 MG CAPSULE is a brand (anda) product labeled by Actavis Pharma, Inc., priced at $8.8237 per EA under NDC 52544008001. Its NADAC has been published 656 times since Dec 5, 2013.
The High Outlier badge above means this manufacturer's average price in the Butalbital, Acetaminophen, and Caffeine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
52544008001
Classification
Brand (ANDA)
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA040885On Market Since
7/29/2013
Pharmacological Classes
Price Statistics
The NADAC for FIORICET 50-300-40 MG CAPSULE has been published 656 times since Dec 5, 2013, and over the history we have for it it has risen 303.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8237 per EA |
|---|---|
| All-time high | $8.8237 (Jun 24, 2026) |
| All-time low | $2.1862 (Dec 5, 2013) |
| 52-week high | $8.8237 |
| 52-week low | $8.0655 |
| Median price | $5.2088 |
| Average price | $5.3697 |
| Largest weekly change | +30.0% (Oct 8, 2014) |
| Weeks tracked | 656 |
| Tracking since | Dec 5, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FIORICET 50-300-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FIORICET 50-300-40 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $8.8237 per EA (NDC 52544008001), effective Jun 24, 2026.
How has the price of FIORICET 50-300-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FIORICET 50-300-40 MG CAPSULE has risen 303.6%. It has been tracked across 656 weekly CMS publications since Dec 5, 2013.
What are the highest and lowest recorded NADAC prices for FIORICET 50-300-40 MG CAPSULE?
Since Dec 5, 2013, the NADAC for FIORICET 50-300-40 MG CAPSULE has ranged from a low of $2.1862 (Dec 5, 2013) to a high of $8.8237 (Jun 24, 2026), with a median of $5.2088 per EA.
Are there cheaper alternatives to FIORICET 50-300-40 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, is $0.3355 per EA — about 96% below FIORICET 50-300-40 MG CAPSULE.
Who manufactures FIORICET 50-300-40 MG CAPSULE?
FIORICET 50-300-40 MG CAPSULE (NDC 52544008001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a brand (anda) product.
Related Drugs
Same classification